(-)-alpha-phellandrene increases expression ISO RGD:1317251 6480464 alpha phellandrene results in increased expression of IRF7 mRNA CTD PMID:25075043 (1->4)-beta-D-glucan multiple interactions ISO RGD:1317252 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of IRF7 mRNA CTD PMID:36331819 (S)-nicotine multiple interactions ISO RGD:1317251 6480464 IRF7 protein mutant form affects the reaction [Nicotine inhibits the reaction [Poly I-C results in increased expression of IFNB1 mRNA]] more ... CTD PMID:31154625 1,1-dichloroethene increases expression ISO RGD:1317252 6480464 vinylidene chloride results in increased expression of IRF7 mRNA CTD PMID:26682919 1,2-dimethylhydrazine increases expression EXP 6480464 1, 2-Dimethylhydrazine results in increased expression of IRF7 mRNA CTD PMID:27840820 1,2-dimethylhydrazine increases expression ISO RGD:1317252 6480464 1, 2-Dimethylhydrazine results in increased expression of IRF7 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:1317252 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of IRF7 mRNA] CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions EXP 6480464 APC protein affects the reaction [1, 2-Dimethylhydrazine results in increased expression of IRF7 mRNA] CTD PMID:27840820 17alpha-ethynylestradiol affects expression ISO RGD:1317252 6480464 Ethinyl Estradiol affects the expression of IRF7 mRNA CTD PMID:17555576 17alpha-ethynylestradiol increases expression ISO RGD:1317252 6480464 Ethinyl Estradiol results in increased expression of IRF7 mRNA CTD PMID:16174780 , PMID:17942748 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of IRF7 mRNA CTD PMID:16174780 , PMID:17557909 17alpha-ethynylestradiol multiple interactions ISO RGD:1317252 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of IRF7 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:1317251 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of IRF7 mRNA, [Estradiol co-treated with TGFB1 protein] results in decreased expression of IRF7 mRNA CTD PMID:19619570 , PMID:30165855 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of IRF7 mRNA CTD PMID:35192832 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IRF7 mRNA CTD PMID:32741896 17beta-estradiol multiple interactions ISO RGD:1317252 6480464 [Polyphenols co-treated with Estradiol] results in increased expression of IRF7 mRNA CTD PMID:30077407 17beta-estradiol increases expression ISO RGD:1317252 6480464 Estradiol results in increased expression of IRF7 mRNA CTD PMID:15289156 more ... 17beta-estradiol increases expression ISO RGD:1317251 6480464 Estradiol results in increased expression of IRF7 mRNA CTD PMID:19619570 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IRF7 mRNA CTD PMID:32741896 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:1317252 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1317252 6480464 Tetrachlorodibenzodioxin results in increased expression of IRF7 mRNA CTD PMID:23798565 , PMID:24058054 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of IRF7 mRNA CTD PMID:32109520 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1317252 6480464 Tetrachlorodibenzodioxin results in decreased expression of IRF7 mRNA CTD PMID:19770486 , PMID:23238561 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of IRF7 mRNA CTD PMID:23238561 , PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1317252 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of IRF7 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1317251 6480464 Tetrachlorodibenzodioxin results in decreased expression of IRF7 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1317251 6480464 Tetrachlorodibenzodioxin results in increased expression of IRF7 mRNA CTD PMID:16704738 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1317251 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of IRF7 mRNA CTD PMID:19619570 2,4-dichlorophenol increases methylation ISO RGD:1317251 6480464 2, 4-dichlorophenol results in increased methylation of IRF7 gene CTD PMID:34523531 2-hydroxypropanoic acid increases expression ISO RGD:1317251 6480464 Lactic Acid results in increased expression of IRF7 mRNA CTD PMID:30851411 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:32119087 3,3',5,5'-tetrabromobisphenol A increases expression EXP 6480464 tetrabromobisphenol A results in increased expression of IRF7 mRNA CTD PMID:27914987 4-(ethoxymethylene)-2-phenyloxazol-5-one increases expression EXP 6480464 Oxazolone results in increased expression of IRF7 mRNA CTD PMID:21893156 4-hydroxynon-2-enal decreases expression ISO RGD:1317252 6480464 4-hydroxy-2-nonenal results in decreased expression of IRF7 mRNA CTD PMID:19191707 5-aza-2'-deoxycytidine increases expression ISO RGD:1317251 6480464 Decitabine results in increased expression of IRF7 mRNA, Decitabine results in increased expression of IRF7 protein CTD PMID:17785578 , PMID:19117987 5-aza-2'-deoxycytidine increases expression ISO RGD:1317252 6480464 Decitabine results in increased expression of IRF7 mRNA CTD PMID:27923600 5-aza-2'-deoxycytidine multiple interactions ISO RGD:1317251 6480464 TNF protein promotes the reaction [Decitabine results in increased expression of IRF7 protein] CTD PMID:19117987 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of IRF7 mRNA CTD PMID:24780913 6alpha-methylprednisolone decreases expression ISO RGD:1317251 6480464 Methylprednisolone results in decreased expression of IRF7 mRNA CTD PMID:19192274 acetamide increases expression EXP 6480464 acetamide results in increased expression of IRF7 mRNA CTD PMID:31881176 aflatoxin B1 affects expression ISO RGD:1317251 6480464 Aflatoxin B1 affects the expression of IRF7 protein CTD PMID:20106945 aldehydo-D-glucose increases expression ISO RGD:1317252 6480464 Glucose results in increased expression of IRF7 mRNA CTD PMID:33448797 aldehydo-D-glucose multiple interactions ISO RGD:1317252 6480464 fucoxanthin inhibits the reaction [Glucose results in increased expression of IRF7 mRNA] CTD PMID:33448797 all-trans-retinoic acid affects expression ISO RGD:1317251 6480464 Tretinoin affects the expression of IRF7 mRNA CTD PMID:15498508 all-trans-retinoic acid increases expression ISO RGD:1317251 6480464 Tretinoin results in increased expression of IRF7 mRNA CTD PMID:15894607 , PMID:33167477 alpha-phellandrene increases expression ISO RGD:1317251 6480464 alpha phellandrene results in increased expression of IRF7 mRNA CTD PMID:25075043 Aroclor 1254 decreases expression ISO RGD:1317251 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of IRF7 mRNA CTD PMID:16934159 arsane increases methylation ISO RGD:1317251 6480464 Arsenic results in increased methylation of IRF7 gene CTD PMID:27838757 arsenic atom increases methylation ISO RGD:1317251 6480464 Arsenic results in increased methylation of IRF7 gene CTD PMID:27838757 arsenous acid decreases expression ISO RGD:1317251 6480464 Arsenic Trioxide results in decreased expression of IRF7 mRNA, Arsenic Trioxide results in decreased expression of IRF7 protein CTD PMID:32642412 azathioprine decreases expression ISO RGD:1317251 6480464 Azathioprine results in decreased expression of IRF7 mRNA CTD PMID:19192274 benzene decreases expression ISO RGD:1317251 6480464 Benzene results in decreased expression of IRF7 mRNA CTD PMID:33064461 benzo[a]pyrene increases expression ISO RGD:1317251 6480464 Benzo(a)pyrene results in increased expression of IRF7 mRNA CTD PMID:20064835 benzo[a]pyrene increases methylation ISO RGD:1317251 6480464 Benzo(a)pyrene results in increased methylation of IRF7 5' UTR, Benzo(a)pyrene results in increased methylation of IRF7 promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:1317252 6480464 Benzo(a)pyrene results in decreased expression of IRF7 mRNA CTD PMID:19770486 , PMID:20713471 benzo[a]pyrene diol epoxide I increases expression ISO RGD:1317251 6480464 7 more ... CTD PMID:19150397 benzo[b]fluoranthene decreases expression ISO RGD:1317252 6480464 benzo(b)fluoranthene results in decreased expression of IRF7 mRNA CTD PMID:26377693 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of IRF7 mRNA CTD PMID:18164116 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1317252 6480464 Diethylhexyl Phthalate results in increased expression of IRF7 mRNA CTD PMID:27405655 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of IRF7 mRNA CTD PMID:25181051 , PMID:34947998 bisphenol A decreases expression ISO RGD:1317252 6480464 bisphenol A results in decreased expression of IRF7 mRNA CTD PMID:35598803 bisphenol A increases expression ISO RGD:1317252 6480464 bisphenol A results in increased expression of IRF7 mRNA CTD PMID:32156529 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of IRF7 mRNA CTD PMID:32145629 bisphenol A affects methylation ISO RGD:1317252 6480464 bisphenol A affects the methylation of IRF7 promoter CTD PMID:27334623 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of IRF7 mRNA CTD PMID:24136188 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of IRF7 mRNA CTD PMID:19167457 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of IRF7 mRNA CTD PMID:25993096 calcitriol multiple interactions ISO RGD:1317251 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of IRF7 mRNA CTD PMID:21592394 calcitriol increases expression ISO RGD:1317251 6480464 Calcitriol results in increased expression of IRF7 mRNA CTD PMID:21592394 carbon nanotube affects expression ISO RGD:1317252 6480464 Nanotubes more ... CTD PMID:23845593 , PMID:25620056 carbon nanotube increases expression ISO RGD:1317252 6480464 Nanotubes more ... CTD PMID:25554681 ceric oxide multiple interactions ISO RGD:1317252 6480464 ceric oxide inhibits the reaction [Antigens, Dermatophagoides results in increased expression of IRF7 mRNA] CTD PMID:29792201 chaetoglobosin A multiple interactions ISO RGD:1317252 6480464 chaetoglobosins inhibits the reaction [Lipopolysaccharides results in increased expression of IRF7 mRNA] CTD PMID:33285210 chloroprene decreases expression EXP 6480464 Chloroprene results in decreased expression of IRF7 mRNA CTD PMID:23125180 cholesterol multiple interactions ISO RGD:1317252 6480464 [Cholesterol co-treated with 1, 2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of IRF7 mRNA CTD PMID:22129739 chromium(6+) multiple interactions ISO RGD:1317251 6480464 AG 1879 inhibits the reaction [chromium hexavalent ion results in increased expression of IRF7 mRNA] more ... CTD PMID:19994902 chromium(6+) affects expression ISO RGD:1317252 6480464 chromium hexavalent ion affects the expression of IRF7 mRNA CTD PMID:28472532 chromium(6+) increases expression ISO RGD:1317252 6480464 chromium hexavalent ion results in increased expression of IRF7 mRNA CTD PMID:19994902 chromium(6+) increases expression ISO RGD:1317251 6480464 chromium hexavalent ion results in increased expression of IRF7 mRNA CTD PMID:19994902 copper atom decreases expression EXP 6480464 Copper results in decreased expression of IRF7 mRNA CTD PMID:30556269 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of IRF7 mRNA CTD PMID:30556269 corn oil increases expression ISO RGD:1317252 6480464 Corn Oil results in increased expression of IRF7 mRNA CTD PMID:33263755 cyclosporin A decreases expression ISO RGD:1317252 6480464 Cyclosporine results in decreased expression of IRF7 mRNA CTD PMID:19770486 D-glucose multiple interactions ISO RGD:1317252 6480464 fucoxanthin inhibits the reaction [Glucose results in increased expression of IRF7 mRNA] CTD PMID:33448797 D-glucose increases expression ISO RGD:1317252 6480464 Glucose results in increased expression of IRF7 mRNA CTD PMID:33448797 diarsenic trioxide decreases expression ISO RGD:1317251 6480464 Arsenic Trioxide results in decreased expression of IRF7 mRNA, Arsenic Trioxide results in decreased expression of IRF7 protein CTD PMID:32642412 dichloroacetic acid decreases expression ISO RGD:1317252 6480464 Dichloroacetic Acid results in decreased expression of IRF7 mRNA CTD PMID:28962523 diclofenac decreases expression ISO RGD:1317251 6480464 Diclofenac results in decreased expression of IRF7 mRNA CTD PMID:19192274 dieldrin decreases expression EXP 6480464 Dieldrin results in decreased expression of IRF7 mRNA CTD PMID:34051100 diethyl malate affects expression ISO RGD:1317252 6480464 diethyl malate affects the expression of IRF7 mRNA CTD PMID:24814887 diethyl maleate decreases expression EXP 6480464 diethyl maleate results in decreased expression of IRF7 mRNA CTD PMID:21161181 diethylstilbestrol increases expression ISO RGD:1317252 6480464 Diethylstilbestrol results in increased expression of IRF7 mRNA CTD PMID:15289156 diethylstilbestrol decreases expression EXP 6480464 Diethylstilbestrol results in decreased expression of IRF7 mRNA CTD PMID:21658437 dioxygen multiple interactions EXP 6480464 [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of IRF7 mRNA], [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of IRF7 mRNA CTD PMID:33729688 diquat decreases expression ISO RGD:1317252 6480464 Diquat results in decreased expression of IRF7 mRNA CTD PMID:36851058 dorsomorphin multiple interactions ISO RGD:1317251 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IRF7 mRNA CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1317251 6480464 Doxorubicin results in decreased expression of IRF7 mRNA CTD PMID:29803840 doxorubicin increases expression ISO RGD:1317252 6480464 Doxorubicin results in increased expression of IRF7 mRNA CTD PMID:31768571 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of IRF7 mRNA CTD PMID:29391264 epoxiconazole decreases expression ISO RGD:1317252 6480464 epoxiconazole results in decreased expression of IRF7 mRNA CTD PMID:35436446 ethanol multiple interactions EXP 6480464 [Fish Oils co-treated with Ethanol] results in increased expression of IRF7 mRNA CTD PMID:17347304 ethanol multiple interactions ISO RGD:1317252 6480464 [Fructose co-treated with Ethanol] results in increased expression of IRF7 protein CTD PMID:26858005 ethanol increases expression ISO RGD:1317252 6480464 Ethanol results in increased expression of IRF7 protein CTD PMID:26858005 ethyl methanesulfonate increases expression ISO RGD:1317251 6480464 Ethyl Methanesulfonate results in increased expression of IRF7 mRNA CTD PMID:23649840 fenofibrate increases expression ISO RGD:1317251 6480464 Fenofibrate results in increased expression of IRF7 mRNA CTD PMID:25572481 ferric oxide decreases expression ISO RGD:1317252 6480464 ferric oxide analog results in decreased expression of IRF7 mRNA CTD PMID:25086211 finasteride decreases expression EXP 6480464 Finasteride results in decreased expression of IRF7 mRNA CTD PMID:24136188 folic acid increases expression ISO RGD:1317252 6480464 Folic Acid results in increased expression of IRF7 mRNA CTD PMID:25629700 folic acid multiple interactions ISO RGD:1317252 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of IRF7 mRNA] CTD PMID:22206623 folic acid affects expression ISO RGD:1317252 6480464 Folic Acid deficiency affects the expression of IRF7 mRNA CTD PMID:32304770 formaldehyde increases expression ISO RGD:1317251 6480464 Formaldehyde results in increased expression of IRF7 mRNA CTD PMID:23649840 fructose multiple interactions ISO RGD:1317252 6480464 [Fructose co-treated with Ethanol] results in increased expression of IRF7 protein CTD PMID:26858005 fructose increases expression ISO RGD:1317252 6480464 Fructose results in increased expression of IRF7 protein CTD PMID:26858005 fucoxanthin multiple interactions ISO RGD:1317252 6480464 fucoxanthin inhibits the reaction [Glucose results in increased expression of IRF7 mRNA] CTD PMID:33448797 furan decreases expression EXP 6480464 furan results in decreased expression of IRF7 mRNA CTD PMID:25539665 genistein increases expression ISO RGD:1317251 6480464 Genistein results in increased expression of IRF7 mRNA CTD PMID:18847459 genistein decreases expression ISO RGD:1317252 6480464 Genistein results in decreased expression of IRF7 mRNA CTD PMID:32186404 genistein increases expression ISO RGD:1317252 6480464 Genistein results in increased expression of IRF7 mRNA CTD PMID:15289156 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of IRF7 mRNA CTD PMID:22061828 , PMID:33387578 geraniol increases expression ISO RGD:1317251 6480464 geraniol results in increased expression of IRF7 mRNA CTD PMID:27683099 glucose increases expression ISO RGD:1317252 6480464 Glucose results in increased expression of IRF7 mRNA CTD PMID:33448797 glucose multiple interactions ISO RGD:1317252 6480464 fucoxanthin inhibits the reaction [Glucose results in increased expression of IRF7 mRNA] CTD PMID:33448797 hydralazine multiple interactions ISO RGD:1317251 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of IRF7 mRNA CTD PMID:17183730 hydroxychloroquine increases expression ISO RGD:1317252 6480464 Hydroxychloroquine results in increased expression of IRF7 mRNA CTD PMID:25321315 isoflavones affects expression ISO RGD:1317251 6480464 Isoflavones affects the expression of IRF7 mRNA CTD PMID:16365062 Licochalcone B increases expression ISO RGD:1317251 6480464 licochalcone B results in increased expression of IRF7 mRNA CTD PMID:33647349 linuron increases expression ISO RGD:1317252 6480464 Linuron results in increased expression of IRF7 mRNA CTD PMID:30661753 linuron multiple interactions ISO RGD:1317252 6480464 XBP1 gene promotes the reaction [Linuron results in increased expression of IRF7 mRNA] CTD PMID:30661753 lipopolysaccharide multiple interactions ISO RGD:1317252 6480464 (+)-JQ1 compound inhibits the reaction [Lipopolysaccharides results in increased expression of IRF7 mRNA] more ... CTD PMID:24056979 more ... lipopolysaccharide multiple interactions ISO RGD:1317251 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of IRF7 mRNA CTD PMID:35811015 lipopolysaccharide increases expression ISO RGD:1317251 6480464 Lipopolysaccharides results in increased expression of IRF7 mRNA CTD PMID:35811015 lipopolysaccharide increases expression ISO RGD:1317252 6480464 Lipopolysaccharides results in increased expression of IRF7 mRNA CTD PMID:24056979 more ... metam multiple interactions ISO RGD:1317252 6480464 methyldithiocarbamate inhibits the reaction [Lipopolysaccharides results in increased expression of IRF7 mRNA] CTD PMID:24056979 metformin multiple interactions ISO RGD:1317251 6480464 [Paclitaxel co-treated with Metformin] results in increased expression of IRF7 mRNA CTD PMID:29309887 methyl methanesulfonate increases expression ISO RGD:1317251 6480464 Methyl Methanesulfonate results in increased expression of IRF7 mRNA CTD PMID:23649840 mitoxantrone affects response to substance ISO RGD:1317251 6480464 IRF7 protein affects the susceptibility to Mitoxantrone CTD PMID:16217747 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of IRF7 mRNA CTD PMID:18164116 N-nitrosomorpholine increases expression EXP 6480464 N-nitrosomorpholine results in increased expression of IRF7 mRNA CTD PMID:19716841 nickel atom increases expression ISO RGD:1317251 6480464 Nickel results in increased expression of IRF7 mRNA CTD PMID:25583101 nickel dichloride decreases expression ISO RGD:1317251 6480464 nickel chloride results in decreased expression of IRF7 mRNA CTD PMID:21466819 nicotine multiple interactions ISO RGD:1317251 6480464 IRF7 protein mutant form affects the reaction [Nicotine inhibits the reaction [Poly I-C results in increased expression of IFNB1 mRNA]] more ... CTD PMID:31154625 nitrates increases expression EXP 6480464 Nitrates results in increased expression of IRF7 mRNA CTD PMID:30022042 orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of IRF7 mRNA CTD PMID:23665939 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of IRF7 mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of IRF7 mRNA, [Topotecan co-treated with oxaliplatin] results in increased expression of IRF7 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:1317252 6480464 [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of IRF7 mRNA CTD PMID:34911549 paclitaxel increases expression EXP 6480464 Paclitaxel results in increased expression of IRF7 mRNA CTD PMID:15585946 paclitaxel multiple interactions ISO RGD:1317251 6480464 [Paclitaxel co-treated with Metformin] results in increased expression of IRF7 mRNA CTD PMID:29309887 paracetamol affects expression ISO RGD:1317252 6480464 Acetaminophen affects the expression of IRF7 mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of IRF7 mRNA CTD PMID:33387578 paracetamol increases expression ISO RGD:1317251 6480464 Acetaminophen results in increased expression of IRF7 mRNA CTD PMID:21420995 , PMID:29067470 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of IRF7 mRNA CTD PMID:32680482 pentachlorophenol increases expression ISO RGD:1317252 6480464 Pentachlorophenol results in increased expression of IRF7 mRNA CTD PMID:23892564 perfluorononanoic acid increases expression ISO RGD:1317251 6480464 perfluoro-n-nonanoic acid results in increased expression of IRF7 mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1317252 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of IRF7 mRNA, [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of IRF7 mRNA CTD PMID:36331819 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of IRF7 mRNA CTD PMID:19162173 phenylephrine decreases expression EXP 6480464 Phenylephrine results in decreased expression of IRF7 mRNA CTD PMID:18158353 pirinixic acid multiple interactions ISO RGD:1317252 6480464 PPARA protein promotes the reaction [pirinixic acid results in decreased expression of IRF7 mRNA] CTD PMID:20059764 pirinixic acid decreases expression ISO RGD:1317252 6480464 pirinixic acid results in decreased expression of IRF7 mRNA CTD PMID:20059764 , PMID:23811191 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of IRF7 mRNA CTD PMID:12832660 more ... poly(I:C) multiple interactions ISO RGD:1317251 6480464 IRF7 protein affects the reaction [Poly I-C results in increased expression of IFNB1 mRNA] more ... CTD PMID:31154625 poly(I:C) multiple interactions EXP 6480464 cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester inhibits the reaction [Poly I-C results in increased expression of IRF7 mRNA] CTD PMID:28726298 poly(I:C) increases expression EXP 6480464 Poly I-C results in increased expression of IRF7 mRNA CTD PMID:28726298 poly(I:C) increases expression ISO RGD:1317251 6480464 Poly I-C results in increased expression of IRF7 mRNA CTD PMID:22240577 , PMID:31154625 prednisolone decreases expression ISO RGD:1317251 6480464 Prednisolone results in decreased expression of IRF7 mRNA CTD PMID:19192274 pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of IRF7 mRNA CTD PMID:19162173 rac-lactic acid increases expression ISO RGD:1317251 6480464 Lactic Acid results in increased expression of IRF7 mRNA CTD PMID:30851411 raloxifene affects expression EXP 6480464 Raloxifene Hydrochloride affects the expression of IRF7 mRNA CTD PMID:16079270 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of IRF7 mRNA CTD PMID:19013527 , PMID:28374803 ruxolitinib decreases expression ISO RGD:1317251 6480464 ruxolitinib results in decreased expression of IRF7 mRNA CTD PMID:22941906 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1317251 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of IRF7 mRNA CTD PMID:35811015 SB 431542 multiple interactions ISO RGD:1317251 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IRF7 mRNA CTD PMID:27188386 silicon dioxide increases expression ISO RGD:1317252 6480464 Silicon Dioxide results in increased expression of IRF7 mRNA CTD PMID:29341224 silver atom affects expression ISO RGD:1317252 6480464 Silver affects the expression of IRF7 mRNA CTD PMID:27131904 silver(0) affects expression ISO RGD:1317252 6480464 Silver affects the expression of IRF7 mRNA CTD PMID:27131904 sodium aurothiomalate decreases expression ISO RGD:1317251 6480464 Gold Sodium Thiomalate results in decreased expression of IRF7 mRNA CTD PMID:19192274 Soman increases expression EXP 6480464 Soman results in increased expression of IRF7 mRNA CTD PMID:19281266 succimer multiple interactions ISO RGD:1317252 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of IRF7 mRNA CTD PMID:21641980 succimer multiple interactions ISO RGD:1317251 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of IRF7 mRNA CTD PMID:26378955 sulforaphane decreases expression ISO RGD:1317251 6480464 sulforaphane results in decreased expression of IRF7 mRNA CTD PMID:31838189 sulindac decreases expression EXP 6480464 Sulindac results in decreased expression of IRF7 mRNA CTD PMID:24136188 sunitinib decreases expression ISO RGD:1317251 6480464 Sunitinib results in decreased expression of IRF7 mRNA CTD PMID:31533062 tamibarotene increases expression ISO RGD:1317251 6480464 tamibarotene results in increased expression of IRF7 mRNA CTD PMID:15498508 tamoxifen affects expression ISO RGD:1317252 6480464 Tamoxifen affects the expression of IRF7 mRNA CTD PMID:17555576 tert-butyl hydroperoxide increases expression ISO RGD:1317252 6480464 tert-Butylhydroperoxide results in increased expression of IRF7 mRNA CTD PMID:14729362 , PMID:15003993 Tesaglitazar decreases expression EXP 6480464 tesaglitazar results in decreased expression of IRF7 mRNA CTD PMID:21515302 testosterone multiple interactions ISO RGD:1317251 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of IRF7 mRNA CTD PMID:21592394 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IRF7 mRNA CTD PMID:32741896 testosterone increases expression ISO RGD:1317251 6480464 Testosterone results in increased expression of IRF7 mRNA CTD PMID:21592394 tetrachloromethane affects expression ISO RGD:1317252 6480464 Carbon Tetrachloride affects the expression of IRF7 mRNA CTD PMID:17484886 tetraphene decreases expression ISO RGD:1317252 6480464 benz(a)anthracene results in decreased expression of IRF7 mRNA CTD PMID:26377693 thapsigargin increases expression ISO RGD:1317251 6480464 Thapsigargin results in increased expression of IRF7 mRNA CTD PMID:22378314 theophylline decreases expression ISO RGD:1317251 6480464 Theophylline results in decreased expression of IRF7 mRNA CTD PMID:16083514 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of IRF7 mRNA CTD PMID:23411599 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of IRF7 mRNA CTD PMID:34492290 titanium dioxide increases expression ISO RGD:1317252 6480464 titanium dioxide results in increased expression of IRF7 mRNA CTD PMID:23557971 , PMID:27760801 tofacitinib decreases expression ISO RGD:1317251 6480464 tofacitinib results in decreased expression of IRF7 mRNA CTD PMID:22941906 , PMID:25487280 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of IRF7 mRNA, [Topotecan co-treated with oxaliplatin] results in increased expression of IRF7 mRNA CTD PMID:25729387 topotecan increases expression EXP 6480464 Topotecan results in increased expression of IRF7 mRNA CTD PMID:25729387 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of IRF7 mRNA CTD PMID:33387578 trimellitic anhydride increases expression EXP 6480464 trimellitic anhydride results in increased expression of IRF7 mRNA CTD PMID:21893156 triptonide increases expression ISO RGD:1317252 6480464 triptonide results in increased expression of IRF7 mRNA CTD PMID:33045310 troglitazone increases expression ISO RGD:1317251 6480464 troglitazone results in increased expression of IRF7 mRNA CTD PMID:25572481 trovafloxacin increases expression ISO RGD:1317252 6480464 trovafloxacin results in increased expression of IRF7 mRNA CTD PMID:35537566 tunicamycin increases expression ISO RGD:1317251 6480464 Tunicamycin results in increased expression of IRF7 mRNA CTD PMID:22378314 valproic acid multiple interactions ISO RGD:1317251 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of IRF7 mRNA more ... CTD PMID:17183730 , PMID:27188386 valproic acid decreases expression ISO RGD:1317251 6480464 Valproic Acid results in decreased expression of IRF7 mRNA CTD PMID:23179753 more ... valproic acid increases methylation ISO RGD:1317251 6480464 Valproic Acid results in increased methylation of IRF7 gene CTD PMID:29154799 valproic acid affects expression ISO RGD:1317251 6480464 Valproic Acid affects the expression of IRF7 mRNA CTD PMID:25979313 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of IRF7 mRNA CTD PMID:19015723 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of IRF7 mRNA CTD PMID:23034163 XL147 multiple interactions ISO RGD:1317252 6480464 XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of IRF7 mRNA] CTD PMID:29891994 zalcitabine multiple interactions EXP 6480464 [gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in increased expression of IRF7 mRNA CTD PMID:18606552 zidovudine multiple interactions ISO RGD:1317251 6480464 [Zidovudine co-treated with IFNA1 protein] results in increased expression of IRF7 mRNA CTD PMID:20370541